Cornerstone Research worked with a life sciences competition expert in a dispute between two pharmaceutical companies that jointly developed a drug.
In a dispute between two pharmaceutical companies that had jointly developed a drug, Cornerstone Research worked with an expert who assessed the business incentives of the company responsible for marketing the drug. This company was alleged to have developed an inappropriate marketing plan because it had other drugs in the therapeutic space that could potentially lose sales to the new drug.
Our expert reviewed the marketing plan at issue and concluded it was consistent with approaches found to be effective by academic researchers.
With Cornerstone Research’s assistance, the expert established that the company had no inherent conflict in promoting the jointly developed drug. The expert also reviewed the marketing plan and concluded it was consistent with approaches found to be effective by academic researchers. An arbitration panel ruled that the company did not face any conflict and the marketing plan was consistent with the company’s obligations under the development agreement.
